Kabat Technique and Neuromuscular Effect in Patients With Bell's Palsy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04807491 |
|
Recruitment Status :
Completed
First Posted : March 19, 2021
Last Update Posted : March 19, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Bell Palsy | Other: Kabat Technique's Other: Neuromuscular Re-Education | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 24 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Effects of Kabat Technique and Neuromuscular Re-Education in Patients With Bell's Palsy |
| Actual Study Start Date : | November 15, 2020 |
| Actual Primary Completion Date : | December 15, 2020 |
| Actual Study Completion Date : | December 30, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Kabat Technique's
Kabat exercises on Upper fulcrum, Intermediate fulcrum and lower fulcrum
|
Other: Kabat Technique's
As with all cranial nerves, some specific techniques can also be applied on the facial nerve to enhance responses and improve recovery; the most important are: The rhythmic start: shows and guides the subject into the movements and the scheme; agonist investigation utilizes sequential concentric and eccentric contractions; The inversion of the antagonist: reinforces responses through the induction phenomenon; Repeated contractions: calls for a response with repeated stretching that briefly enables movement; Isometric contractions: for stabilizing and reinforcing the response. Conventional therapy exercises |
|
Experimental: Neuromuscular Re-Education:
For initiation, Facilitation, Movement control and movement control
|
Other: Neuromuscular Re-Education
After the baseline assessment, the participant in the control will receive Neuromuscular Re-Education. The duration of session will be 45 minutes.Neuromuscular Re-Education: For initiation (acute phase): Active-assisted exercise,Massage and stretch for affected side.For Facilitation ,Active-assisted exercise.For Movement control:Massage and stretching for facial retraction,Assisted and active exercises on involved side. For Relaxation,Thermotherapy,Relaxation exercises,Alternating rhythmic movements. Conventional therapy exercises |
- SunnyBrook Facial Grading System [ Time Frame: 4 weeks ]the tool is used to assess changes from baseline to 4 weeks The Sunnybrook scale is a regional weighted scale based on evaluation of different regions including resting symmetry, symmetry of voluntary movement and severity of Synkinesis to form one single composite score from 0 to 100. It was devised and established at the Sunnybrook Health Sciences Centre in Toronto having an intraclass correlation coefficient (ICC) of 0.890. The Facial Grading System is a tool used for clinical evaluation of Facial Nerve function. It is intended to use on peoples with facial nerve weaknes.
- Facial Disability Index [ Time Frame: 4 weeks ]the tool is used to assess changes from baseline to 4 weeks The Facial Disability Index (FDI) is a condition-specific scale that is proposed to be used to help clinicians in making decisions about individual patients and to differentiate among individuals with different levels of disability and to evaluate change within a person over time. It have 2 domains, i.e. physical function and social wellbeing. It have total 10 questions, 5/domain. Each item is rated on a 6-point scale, ranging from severe disability to absence of disability. Both subscales are transformed to a score on a 100-point scale, with 100 indicating unimpaired physical or social/well-being function.
- Synkinesis Assessment Questionnair: [ Time Frame: 4 weeks ]the tool is used to assess changes from baseline to 4 weeks The Synkinesis Assessment Questionnaire (SAQ) is a valid, reliable, and easily administered instrument for the self-assessment of synkinesis in patients with facial palsy. This instrument was developed and validated in the Facial Nerve Center at the Massachusetts Eye and Ear Infirmary (Boston, USA) in 2007. The questionnaire consists of nine items. Total scores range from 0 (no synkinesis) to 100 (severe synkinesis, all the time). The SAQ is a reliable and valid tool having the Cronbach alpha for the final SAQ was 0.859
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 50 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Diagnosed cases of bell's palsy
- Non traumatic onset ( conditions like infectious, hypertensive patients, diabetic patients
Exclusion Criteria:
-
• History of significant psychiatric illness
- Upper motor neuron disease ( stroke, TBI, tumor)
- Non co-operative patients
- Post-surgical case
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04807491
| Pakistan | |
| Riphah International University | |
| Islamabad, Pakistan, 44000 | |
| Principal Investigator: | Dr Aruba Saeed, PHD* | Riphah International University |
| Responsible Party: | Riphah International University |
| ClinicalTrials.gov Identifier: | NCT04807491 |
| Other Study ID Numbers: |
REC/00659 Muhammad Kashif |
| First Posted: | March 19, 2021 Key Record Dates |
| Last Update Posted: | March 19, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Bell Palsy PNF Kabat therapy synkinesis |
|
Bell Palsy Facial Paralysis Paralysis Neurologic Manifestations Nervous System Diseases Herpesviridae Infections DNA Virus Infections |
Virus Diseases Infections Mouth Diseases Stomatognathic Diseases Facial Nerve Diseases Cranial Nerve Diseases |

